Phenome-wide association study using research participants' self-reported data provides insight into the Th17 and IL-17 pathway

A phenome-wide association study of variants in genes in the Th17 and IL-17 pathway was performed using self-reported phenotypes and genetic data from 521,000 research participants of 23andMe. Results replicated known associations with similar effect sizes for autoimmune traits illustrating self-rep...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2017-11, Vol.12 (11), p.e0186405-e0186405
Hauptverfasser: Ehm, Margaret G, Aponte, Jennifer L, Chiano, Mathias N, Yerges-Armstrong, Laura M, Johnson, Toby, Barker, Jonathan N, Cook, Suzanne F, Gupta, Akanksha, Hinds, David A, Li, Li, Nelson, Matthew R, Simpson, Michael A, Tian, Chao, McCarthy, Linda C, Rajpal, Deepak K, Waterworth, Dawn M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A phenome-wide association study of variants in genes in the Th17 and IL-17 pathway was performed using self-reported phenotypes and genetic data from 521,000 research participants of 23andMe. Results replicated known associations with similar effect sizes for autoimmune traits illustrating self-reported traits can be a surrogate for clinically assessed conditions. Novel associations controlling for a false discovery rate of 5% included the association of the variant encoding p.Ile684Ser in TYK2 with increased risk of tonsillectomy, strep throat occurrences and teen acne, the variant encoding p.Arg381Gln in IL23R with a decrease in dandruff frequency, the variant encoding p.Asp10Asn in TRAF3IP2 with risk of male-pattern balding, and the RORC regulatory variant (rs4845604) with protection from allergies. This approach enabled rapid assessment of association with a wide variety of traits and investigation of traits with limited reported associations to overlay meaningful phenotypic context on the range of conditions being considered for drugs targeting this pathway.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0186405